Annual report pursuant to Section 13 and 15(d)

NET INCOME (LOSS) PER SHARE (Tables)

v3.24.1.1.u2
NET INCOME (LOSS) PER SHARE (Tables)
 12 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of antidilutive securities excluded from computation of diluted net income (loss) per share
The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders (in thousands, except per share data):
Year Ended March 31,
2024 2023 2022
As Restated As Restated
Numerator:
Net income (loss) attributable to common stockholders used in basic earnings per share $ (41,286) $ (18,368) $ 38,355 
Add back: Excluded (gain) loss on assumed exercise of liability-classified common stock warrants during the period —  (7,323) (59,753)
Net loss attributable to common stockholders used in diluted earnings per share $ (41,286) $ (25,691) $ (21,398)
Denominator:
Weighted average common shares outstanding used in basic earnings per share 95,087  90,348  58,871 
Incremental common shares from:
Assumed exercise of dilutive warrants —  840  7,146 
Weighted average common shares outstanding used in diluted earnings per share 95,087  91,188  66,017 
Net income (loss) per share attributable to common stockholders - Basic $ (0.43) $ (0.20) $ 0.65 
Net income (loss) per share attributable to common stockholders - Diluted $ (0.43) $ (0.28) $ (0.32)
The dilutive impact related to shares of common stock from incentive plans and outstanding warrants is determined by applying the treasury stock method to the assumed vesting of outstanding performance share units and restricted stock units and the exercise of outstanding options and warrants. The dilutive impact related to shares of common stock from contingently issuable performance share units is determined by applying a two-step approach using both the contingently issuable share guidance and the treasury stock method.
The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (in thousands):
Year Ended March 31,
2024 2023 2022
Stock awards 336  543  1,996 
Warrants 12,164  3,706  50 
ESPP —  8  11 
Total 12,500  4,257  2,057